Clinical Trial Update: Testing Miglustat Administration in Subjects With Spastic Paraplegia 11 [Phase 2]

View source ↗

Summary

Phase 2 trial update on miglustat administration in subjects with hereditary spastic paraplegia (Hereditary Spastic Paraparesis), status completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hereditary Spastic Paraparesis

Drugs mentioned

• Miglustat (miglustat)

Snippet

Sponsor: IRCCS Fondazione Stella Maris | Conditions: Hereditary Spastic Paraparesis | Phase 2 | Status: COMPLETED